loader image
Monday, December 22, 2025
78.3 F
McAllen
- Advertisement -

U.S. Overdose Deaths Decrease in 2023

Health & Lifestyle
264

Listen to article (english)

Translate to Spanish or other 102 languages!

There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022.  Image for illustration purposes
There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022.  Image for illustration purposes

Mega Doctor News

- Advertisement -

Newswise — According to the Centers for Disease Control, preliminary data shows drug overdose deaths decreased by three percent in 2023. This would be the first annual decrease in drug overdose deaths since 2018. 

There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022. 

Nebraska, Kansas, Indiana and Maine saw decreases of more than 15 percent. 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Pioneering gene therapy restores deaf toddler’s hearing
Next article
Surprising Health Benefits of Pickles

More Articles

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×